Advertisement

Reactions Weekly

, Volume 1733, Issue 1, pp 323–323 | Cite as

Vemurafenib

Photosensitivity with recurrent angioedema: case report
Case report
  • 12 Downloads

Reference

  1. Tardieu M, et al. Cutaneous adverse events in children treated with BRAF-inhibitor vemurafenib for refractory BRAF (V600E) mutated langerhans cell histiocytosis: A european cohort study. Pediatric Blood and Cancer 66 (Suppl. 1): e27548, Jan 2019. Available from: URL: http://doi.org/10.1002/pbc.27548 [abstract] - France

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations